PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10

Reported: August 31, 2022 Initiated: July 27, 2022 #D-1362-2022

Product Description

Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10

Reason for Recall

Failed dissolution specifications.

Details

Units Affected
4,309 bottles
Distribution
USA nationwide
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Extended Release Tablets, USP, 250 mg, packaged in 100-count bottle, Rx only, Manufactured by: Amneal Pharmaceuticals, India, Distributed by: Amneal Pharmaceuticals, Bridgewater, NJ, NDC 65162-755-10. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 4,309 bottles.
Why was this product recalled?
Failed dissolution specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 31, 2022. Severity: Moderate. Recall number: D-1362-2022.